Category - Markets

Markets

Tivic rebrands as Valion Bio and changes ticker, closes down 28%

After changing its name from Tivic Health Systems (NASDAQ: TIVC) to Valion Bio (NASDAQ: VBIO), effective at market open today, the company’s stock price declined 28% to close at $1.01, after trading as low as $0.865...

April 28, 2026

Markets

Stifel starts Immunic at buy; PT $2.50

Stifel initiated coverage of Immunic (NASDAQ: IMUX) with a “buy” rating and price target of $2.50. The stock closed at $1.11 on April 15. Immunic is a biotechnology company developing vidofludimus calcium (VidoCa) for...

April 16, 2026

Markets

Rodman & Renshaw starts TuHURA at buy; PT $7

Rodman & Renshaw initiated coverage of TuHURA Biosciences (NASDAQ:HURA) with a “buy” rating and price target of $7.00. The stock closed at $3.15 on April 14th. TuHURA is currently undertaking a Phase 3 trial for its...

April 15, 2026

Markets

Piper starts Adagio at overweight; PT $3

Piper Sandler initiated coverage of Adagio Medical Holdings (NASDAQ: ADGM) with an “overweight” rating and price target of $3.00. The stock closed at $1.33 on April 13th. Adagio is a pre-commercial medtech company that...

April 14, 2026

Markets

Stifel starts Tectonic Therapeutic at buy; PT $75

Stifel initiated coverage of Tectonic Therapeutic (NASDAQ:TECX) with a “buy” rating and price target of $75.00. The stock closed at $29.96 on April 13. Tectonic is a clinical-stage biotech, developing therapies...

April 13, 2026

Markets

Clear Street upgrades Korro Bio to buy; PT to $18.00 from $10.00

Clear Street upgraded Korro Bio (NASDAQ: KRRO) to “buy” from “hold” and raised its price target to $18.00 from $10.00, following Korro’s late January Analyst Day detailing their new lead program, KRRO-121 for...

February 18, 2026

Markets

Lake Street sees CMS’s proposed 2026 TULSA reimbursement as favorable

Lake Street Capital Markets senior research analyst, Ben Haynor, issued a research note today on Profound Medical (NASDAQ:PROF; TSX:PRN), reiterating his ‘buy’ rating and $11 target price on the company’s stock...

July 16, 2025

Markets

Light AI goes public on CBOE Canada, stock rallies on first day of trading

Light AI (CBOE CA: ALGO) announced the completion of its IPO (including the agents’ full exercise of their over-allotment option) and began trading on CBOE Canada today. Including the units sold pursuant to the over...

January 8, 2025

Markets

Lake Street analyst pitches Profound Medical as one of his ‘best ideas’ for 2025

Lake Street Capital Markets senior research analyst, Ben Haynor, issued a research note today on Profound Medical (NASDAQ:PROF; TSX:PRN), reiterating his ‘buy’ rating and $17 target price on the company’s stock...

January 2, 2025

Markets

Clear Street initiates coverage of several healthcare stocks

Analysts Kaveri Pohlman, PhD and Bill Maughan, PhD from Clear Street, a cloud-native financial technology firm on a mission to modernize the brokerage ecosystem, have launched coverage of several healthcare names. “The...

December 11, 2024

Category - Markets

Subscribe